Начало・Списък с акции・iRhythm Technologies Inc

iRhythm Technologies Inc

Отворен

СекторЗдравеопазване

127.24 2.23

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

123.51

Максимум

127.16

Ключови измерители
By Trading Economics
Приходи	-20M -14M
Продажби	-9.5M 199M
EPS	-0.35
Марж на печалбата	-6.988
Служители	2,400
EBITDA	-20M -3.6M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+40.29% upside

Дивиденти
By Acuity
Следващи печалби	6.08.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-453M 3.7B
Предишно отваряне	125.01
Предишно затваряне	127.24

Настроения в новините

By Acuity

50%

151 / 340 Класиране в Healthcare

iRhythm Technologies Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.08.2026 г., 20:03 ч. UTC

iRhythm Technologies Inc shares are rising, driven by gains in the Health Care Equipment sub-sector and overall strong market performance.

31.07.2026 г., 21:01 ч. UTC

iRhythm Technologies Inc shares advanced in after-hours trading, reflecting unusual strength amid rising inflation concerns and geopolitical tensions affecting oil prices.

30.07.2026 г., 19:43 ч. UTC

iRhythm Technologies Inc is lower today, influenced by declines in the Health Care Equipment sub-sector. This follows five consecutive sessions of gains.

29.07.2026 г., 19:52 ч. UTC

Macro Event

iRhythm Technologies shares are higher today, reflecting positive momentum after the Federal Reserve maintained interest rates amid easing inflation concerns.

28.07.2026 г., 18:03 ч. UTC

iRhythm Technologies is higher today, driven by gains in the Health Care Equipment sub-sector. Shares pulled back from earlier session highs.

27.07.2026 г., 20:06 ч. UTC

iRhythm Technologies Inc shares are higher amid positive market sentiment, driven by a decline in oil prices and easing geopolitical tensions.

24.07.2026 г., 20:06 ч. UTC

iRhythm Technologies Inc shares are trading higher, reflecting positive sentiment amid falling oil prices that ease inflation concerns. No specific company news was identified.

23.07.2026 г., 09:01 ч. UTC

iRhythm Technologies Inc is trading higher in pre-market hours, reflecting a notable gain since Wednesday's close. No specific news was identified for this movement.

21.07.2026 г., 18:56 ч. UTC

News

iRhythm Technologies is under investigation for potential wrongdoing by certain officers and directors, contributing to lower trading during Tuesday's session.

20.07.2026 г., 19:16 ч. UTC

iRhythm Technologies Inc is trading higher Monday, having reached a peak cumulative return earlier in the session. No specific news was identified to explain the movement.

Сравнение с други в отрасъла

Ценова промяна

iRhythm Technologies Inc Прогноза

Ценова цел

By TipRanks

40.29% нагоре

12-месечна прогноза

Среден 174.88 USD 40.29%

Висок 255 USD

Нисък 150 USD

Според 9 анализатори от Wall Street, предложили 12-месечна ценова цел за iRhythm Technologies Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

9 ratings

Купи

Задържане

Продай

Според 9 анализатори, дали борсови рейтинги на iRhythm Technologies Inc през последните 3 месеца.

Настроение

By Acuity

151 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.